The Adam Gaertner Interview – Part 1
One of the most active analysts during this pandemic regarding the treatment of COVID-19 has been independent researcher Adam Gaertner. He started looking for therapeutic
One of the most active analysts during this pandemic regarding the treatment of COVID-19 has been independent researcher Adam Gaertner. He started looking for therapeutic
This article presents a real world experience in a major food processing corporation in Brazil, with 12,000 employees, where there were increasing COVID-19 infections despite
This article looks at the coverage of COVID-19 by Dr Mehmet Cengiz Öz, from courageous reporting on early treatment at the beginning of the pandemic,
Considering the burden on hospitals, the decision was made to treat the asymptomatic and mild cases at home and moderate and severe cases in the hospitals.
“We live in a strange post-truth world devoid of honest free speech, integrity, compassion & science.” — Professor Robert Clancy Selected Highlights both early treatment
This 30 min interview reviews the whereabouts of C19 treatments since the beginning of the pandemic, both at US and global levels, with emphasis on
Learn about the best practices for treating older people, at home or in nursing homes, drawing from the practical experience of two of the very
INSERM – the “Institut national de la santé et de la recherche médicale” i.e. the French National Institute of Health and Medical Research, has issued
A new group called “Doctors for Justice in LTC” – LTC standing for Long Term Care Facilities – has launched a website, stating their views
On January 22, the Montreal Heart Institute released a media communiqué about the results of the “COLCORONA” clinical trial on the use of colchicine to
The first part of this article is about prophylaxis for high risk people and about the early treatment of COVID-19 in nursing homes. It relies
A new legal attempt to have ivermectin approved in France, through a Temporary Recommendation for Use, will be presented this Monday January 25 to the